Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 04-2023 | 01-2023 | 10-2022 | 07-2022 | 04-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -761 | -7,172 | -6,607 | -3,197 | -2,360 |
| Depreciation Amortization | N/A | 14 | 10 | 7 | 4 |
| Accounts receivable | -15 | 237 | 221 | 239 | 248 |
| Other Working Capital | -537 | 2,627 | 1,802 | 1,879 | 1,650 |
| Other Operating Activity | 243 | 3,143 | 3,549 | 507 | 141 |
| Operating Cash Flow | $-1,070 | $-1,151 | $-1,024 | $-566 | $-318 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,022 | 926 | 446 | 197 |
| Other Financing Activity | 1,258 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,258 | $1,022 | $926 | $446 | $197 |
| Exchange Rate Effect | 0 | 2 | -1 | -3 | -5 |
| Beginning Cash Position | 7 | 133 | 130 | 135 | 137 |
| End Cash Position | 195 | 6 | 31 | 11 | 11 |
| Net Cash Flow | $189 | $-126 | $-99 | $-124 | $-126 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,070 | -1,151 | -1,024 | -566 | -318 |
| Free Cash Flow | -1,070 | -1,151 | -1,024 | -566 | -318 |